APOBEC3A and cervical cancer: Our study demonstrated that ectopically expressed APOBEC3A caused cell-cycle arrest in the S-phase and downregulated the G2 stage, suggesting that APOBEC3A inhibits the ATR-Chk1 pathway in cervical cancer cells, leading to cell death.